NEW ENTERPRISE ASSOCIATES 13 LP - 31 Mar 2025 SCHEDULE 13G/A Report for Sagimet Biosciences, Inc. Series A Common Stock, $0.0001 par value per share (SGMT)

Filing Manager
NEW ENTERPRISE ASSOCIATES 13 LP
Reporting Manager
New Enterprise Associates 13, L.P.
Security
Sagimet Biosciences, Inc. Series A Common Stock, $0.0001 par value per share
Symbol
SGMT
Disclosed Ownership
0 shares
Ownership
0%
Form type
SCHEDULE 13G/A
Filing time
13 May 2025, 16:15:21 UTC
Date of event
31 Mar 2025
SEC
View on sec.gov

Reporting Managers (8)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
New Enterprise Associates 13, L.P. 0% 0 0 0 /s/ Zachary Bambach Zachary Bambach as attorney-in-fact for Anthony A. Florence Jr., Managing Partner and Co-Chief Executive Officer
NEA Partners 13, L.P. 0% 0 0 0 /s/ Zachary Bambach Zachary Bambach as attorney-in-fact for Anthony A. Florence Jr., Managing Partner and Co-Chief Executive Officer
NEA 13 GP, LTD 0% 0 0 0 /s/ Zachary Bambach Zachary Bambach as attorney-in-fact for Anthony A. Florence Jr., Managing Partner and Co-Chief Executive Officer
Forest Baskett 0% 0 0 0 /s/ Zachary Bambach Zachary Bambach as attorney-in-fact for Forest Baskett
Anthony A. Florence, Jr. 0% 0 0 0 /s/ Zachary Bambach Zachary Bambach as attorney-in-fact for Anthony A. Florence Jr.
Patrick J. Kerins 0% 0 0 0 /s/ Zachary Bambach Zachary Bambach as attorney-in-fact for Patrick J. Kerins
Mohamad H. Makhzoumi 0% 0 0 0 /s/ Zachary Bambach Zachary Bambach as attorney-in-fact for Mohamad H. Makhzoumi
Scott D. Sandell 0% 0 0 0 /s/ Zachary Bambach Zachary Bambach as attorney-in-fact for Scott D. Sandell